Banner

ISTA acquires rights to 3 ophthalmic compounds

Article

Irvine, CA-ISTA Pharmaceuticals, Irvine, CA, entered into an agreement with AcSentient Inc. under which ISTA will acquire rights to three late-stage ophthalmology compounds.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.